Medical Cannabis and Cancer Research Get $ 1.5 Million Boost

The first findings from the UK’s largest medical cannabis patient study show that quality of life has improved by more than 50 percent.

According to preliminary results from the drug science project Twenty21 study, medical cannabis can be used in people with life-threatening conditions such as chronic pain, multiple sclerosis (MS) Tourette’s syndrome, and post-traumatic stress disorder (PTSD). It has been found to significantly improve quality of life.

Published on Tuesday, May 11th report Is the first real-world data collected on medical cannabis in the United Kingdom.

Launched in 2019, Project Twenty 21 currently authorizes more than 900 patients who were unable to control their condition with commonly prescribed medications to prescribe medical cannabis.

Those advances have been evaluated using established methodologies used to study the well-being of patients with cancer, cardiovascular disease, dementia and many other conditions.

The results show that patients’ self-reported health and ability to lead a more normal life increased by 51% and significantly improved management of debilitating secondary conditions such as anxiety, insomnia and depression. ..

All enrolled patients had at least two “treatment failures” in their medical records. Commonly prescribed medications such as opioids had little or no effect on the ability to manage the condition.

Sixty-four percent of the patients involved in this study were identified as male, 35% female, and one non-binary, with an average age of 39.9 years.

The majority of patients (56%) reported chronic pain as the main condition.

By March 13, 2021, a total of 75 individuals had completed both the first and three-month follow-up bookings. This shows the life-improving effect of prescribed medical cannabis on improving health.

Dr. Anne Katrin Schlag, Principal Investigator of Drug Science

Dr. Anschlag, director of drug science, the organization behind the project and Honorary Fellow of Imperial College London, said: “”Our patient population is often made up of a vast age group with multiple health problems. The poor quality of life they experience shows how sick many of them are.

“The stereotype of medical cannabis users as young and healthy recreational users looking for legitimate sources could not be far from the truth.”

Talking to cannabis health, she said Given the patient’s overall quality of life, treatment of the patient’s secondary condition was “essential.”

“The majority of patients are in a secondary condition, with up to 10 of them,” said Dr. Schlag.

“The most common secondary conditions diagnosed were depression, back and neck problems. insomnia, Stress and anxiety, All of these can have a serious negative impact on a patient’s quality of life.

“This large number of multiple prevalences have excluded many of these patients from formal randomized controlled trials, highlighting the importance of real-world evidence databases such as Twenty21.”

Almost two-thirds (63%) of patients in this study previously turned to the use of illegal cannabis to treat their condition, but legal prescriptions help avoid crime. I was able to do.

Prescriptions also offer the opportunity to reduce and stop reliance on widely available medicines that can have serious side effects, including addiction, according to researchers.

This report follows the guidance of the National Institute for Clinical Excellence (NICE), published in April 2021, and states: [commonly prescribed drugs, such as benzodiazepines or opioids] It makes some difference in people’s quality of life, pain, or psychological distress, but it can be harmful, including the possibility of addiction.

Drug science experts Called before To allow NICE and other regulators to review medical cannabis guidance and provide patients with another viable option.

Dr. Schlag told Cannabis Health that the impact of medical cannabis on opioid use will be analyzed in future reports.

“Current papers show that the vast majority of patients use medical cannabis to treat their pain, but it’s still unclear if this has led to opioid savings,” she added.

Through Project Project Twenty21, DrugScience aims to build tThe UK’s greatest evidence of the effectiveness of medical cannabis, hoping that the findings will lead to NHS funding that outweighs the potential risks of treatment.

Founder and professor of drug science David nutt, Comment: “The lack of clinical evidence makes it difficult for doctors to confidently prescribe legal medical cannabis in the UK. These new discoveries have made great strides and what these drugs are. It helps to uncover the benefits to thousands of seriously ill patients. “

The scheme subsidizes prescriptions for qualified patients to access affordable treatment through many UK clinics.

CEO, Eric Bystrom CherenA Project Twenty21 prescribing clinic said the findings were “important” for a better understanding of medical cannabis, adding: For the first time, we have obtained meaningful data and research from the United Kingdom.

“This is important because it begins to provide data to clinicians and promotes education and understanding of medical cannabis in the United Kingdom.”

How about becoming a patient with Project Twenty21?

My Experience as a Medical Cannabis Prescriber at Project Twenty 21

Medical Cannabis and Cancer Research Get $ 1.5 Million Boost

Source link Medical Cannabis and Cancer Research Get $ 1.5 Million Boost

Related Articles

Back to top button